BenefitsLink logo
EmployeeBenefitsJobs logo
Free Daily News and Jobs

“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
Featured Jobs

Employee Benefits Attorney (Indianapolis IN)
Plan Administrator (Huntington Beach CA / Ballston Lake NY)
Defined Contribution Administrator (Oak Brook IL)
Associate Fund Counsel (Washington DC)
Get the BenefitsLink app LinkedIn

News Items, by Subject

Health plan costs - prescription drugs

Now Viewing
View Excerpts and

33% of U.S. Workforce Using Prescription Pain Medications
Eliminating Drug Rebates: How Might Access and Pricing be Affected?
[Opinion] Reining In Drug Costs: No Easy Fix
Senate Hearing on Drug Pricing Provides a Lesson in What PBMs Do
Maryland at the Forefront of Groundbreaking Legislation to Lower Drug Prices
[Opinion] American Benefits Council Comment Letter to HHS on Proposed Regs for Prescription Drug Rebates and Safe Harbors
Senate Bill Would End Drug Rebates in Employer Plans
Administration's 2020 Budget Proposal Addresses Retirement, Health Care and Paid Leave
[Opinion] American Academy of Actuaries Letter to CMS on Changes to Safe Harbors for Rebates Involving Prescription Pharmaceuticals (PDF)
Cigna, Express Scripts Capping Insulin Co-Pays to $25 for Participating Commercial Members
Drug Rebates May Soon Be a Thing of the Past
How Health Plans Are Tackling the Opioid Crisis (PDF)
What's Hiding in Your Specialty Drug Claim Costs?
HHS's Proposed Modification of Pharmacy Rebate Safe Harbors (PDF)
Kentucky Launches Probe Into Drug Overcharges by Pharmacy Benefit Managers
HHS Proposes Changes to Rebates for Part D Plans Under the Anti-Kickback Statute
17 Ways Employers Are Fighting Prescription Drug Costs
Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid: An In-Depth Analysis (PDF)
CMS Updates Drug Dashboards with Prescription Drug Pricing and Spending Data
House Committee Hearing on Lowering the Cost of Prescription Drugs: Reducing Barriers to Market Competition
[Guidance Overview] HHS Proposed Rule Could Significantly Impact Drug Manufacturers, PBMs, and Other Stakeholders
UnitedHealthcare Will Expand a Drug Discount Program Aimed at Lowering Consumer Costs
Lawmakers United Against High Drug Prices Bare Partisan Teeth
Senate Finance Committee Hearing: Drug Pricing in America: A Prescription for Change, Part 2
Key Takeaways from Pharma Testimony at Senate Drug Pricing Hearing
In Florida, Drug Re-Importation from Canada Finds New Champions, Old Snags
Congress Mulls Cap on What Medicare Enrollees Pay for Drugs
[Opinion] American Benefits Council Comment Letter to HHS on Notice of Benefit and Payment Parameters for 2020
Supreme Court Deals a Fatal Blow to Maryland Drug 'Price Gouging' Law
Lowering Drug Costs: New Proposed Rule Targets Drug Rebates
Express Scripts Reports Record Low Drug Trend Across Commercial Plans in 2018
Remote Prescribing Trends in Telehealth
House Ways & Means Committee Hearing: The Cost of Rising Prescription Drug Prices
[Guidance Overview] HHS Proposes Rule to Eliminate Safe Harbor for PBM Drug Rebates
Administration Salutes Parade of Generic Drug Approvals, But Hundreds Aren't Yet on the Market
[Guidance Overview] HHS Aims to Reduce Prescription Drug Prices Through Proposed Changes to the Anti-Kickback Statute's Safe Harbors
[Guidance Overview] HHS OIG Proposes Anti-Kickback Safe Harbor Amendments to Regulate and Restrict the Provision of Manufacturer Remuneration to Plan Sponsors and PBMs
[Guidance Overview] HHS Proposes New Rules to Eliminate Drug Rebates and Encourage Direct Discounts
[Guidance Overview] Sweeping Changes Proposed to Safe Harbors for Drug Discounts to Health Plans
[Guidance Overview] HHS Proposes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors
[Guidance Overview] Administration Releases Long-Awaited Drug Rebate Proposal
Winners and Losers Under HHS Plan to Slash Drug Rebate Deals
Impact of Potential Changes to the Treatment of Drug Manufacturer Rebates (PDF)
HHS Proposal Could Kill PBM Rebates
[Official Guidance] Text of HHS Proposed Regs: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain PBM Fees
[Guidance Overview] Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct Discounts to Patients
Provider Payments Criticized as Congress Targets High Drug Costs
[Opinion] Comprehensive Reform to Lower Prescription Drug Prices
Essential Facts About Medicare and Prescription Drug Spending
Congress Wades Into Debate Over High-Cost Prescription Drugs; Pharma Execs Refuse to Testify
Senate Finance Committee Hearing: Drug Pricing in America -- A Prescription for Change, Part I
California Makes Waves with Pharma Benefits, Purchasing Plan
CMS Addresses Drug Manufacturer Coupons in Proposed 2020 Payment Notice
TRICARE Issues Request for Information on Formulary Management
Including Drug Prices in TV Ads May Deter Consumers from High-Priced Drugs
HHS Proposals Could Increase Health Costs for Consumers
California Prescription Drug Purchasing Initiative Raises Numerous Questions
[Guidance Overview] CMS Announces New Model to Lower Drug Prices in Medicare Part D and Transformative Updates to Existing Model for Medicare Advantage
Drug-Pricing Transparency, Vertical PBM Deals Are Top of Mind for Employers in 2019
Bringing 'Transparent Thinking' to PBM Management (PDF)
About Us


Privacy Policy

Post a Job

Advertise in the BenefitsLink Newsletters

Add Your Company to the Directory of Vendors and Software

Submit a News Item, Press Release, Webcast or Conference

Contact Us

Payment Portal

© 2019, Inc.